Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amikacin retinal toxicity.

Literature DB >> 10636651

Amikacin retinal toxicity.

T L Jackson, T H Williamson.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1999 PMID： 10636651 PMCID： PMC1722806 DOI： 10.1136/bjo.83.10.1194f

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Macular infarction after intravitreal amikacin: mounting evidence against amikacin.

Authors: G Galloway; A Ramsay; K Jordan; A Vivian
Journal: Br J Ophthalmol Date: 2002-03 Impact factor: 4.638

2. [Rational antibiotic therapy in ophthalmology].

Authors: W Behrens-Baumann; U Frank; T Ness
Journal: Ophthalmologe Date: 2010-04 Impact factor: 1.059

3. Optical coherence tomography and fundus fluorescein angiography of a case of macular toxicity from intravitreal amikacin.

Authors: Damien Chia Ming Yeo; Dongying Zhao; Matthew Smith; Ayad Al-bermani
Journal: BMJ Case Rep Date: 2016-02-26

4. Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?

Authors: Ashok Kumar Reddy; Raja Rami Reddy; Muralidhar Rao Paruvelli; Srinivas Ambatipudi; Alka Rani; Sikander A K Lodhi; Juturi Maruthi Lokabhi Reddy; K Ramakanth Reddy; Niraj Pandey; Rituraj Videkar; Manish Kumar Sinha; Ajit Babu Majji; Nilanjana Deb-Jorder; Atul Kumar Sahu; Jyostna Myneni; Anina Abraham
Journal: Int Ophthalmol Date: 2014-11-11 Impact factor: 2.031

5. [Prophylaxis and therapy of postoperative endophthalmitis. Criticism of the ESCRS study and the Early Vitrectomy study].

Authors: W Behrens-Baumann
Journal: Ophthalmologe Date: 2011-11 Impact factor: 1.059

Amikacin retinal toxicity.

1. Macular infarction after intravitreal amikacin: mounting evidence against amikacin.

2. [Rational antibiotic therapy in ophthalmology].

3. Optical coherence tomography and fundus fluorescein angiography of a case of macular toxicity from intravitreal amikacin.

4. Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?

5. [Prophylaxis and therapy of postoperative endophthalmitis. Criticism of the ESCRS study and the Early Vitrectomy study].

6. Toward improving therapeutic regimens for Bacillus endophthalmitis.

7. Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

8. A sudden total loss of vision after routine cataract surgery.

9. Macular ischemia after intravitreal amikacin on patient with intraocular foreign body.